Oct. 26, 2019
Laura Minarsch, President at MMC Medical International Services
Laura Minarsch, R.T. RCIS, CVT, is a senior clinical affairs strategist and President of MMC Medical International Services. She consults for several novel innovative device companies in the MedTech space and has facilitated numerous acquisitions over her career spanning more than 25 years. Her track record is based on successful and strategically planned “First in Human” submissions and clinical studies in Europe, Canada, South America, New Zealand, and Australia. She has been instrumental in defining key scientific relationships with opinion leaders and strategic partners. Additionally, she has achieved several record critical project timelines resulting in optimized operations and realized corporate objectives.
Laura began her career as a Registered Cardiovascular Invasive Specialist, and Interventional Cardiovascular Specialist implementing several first interventional device programs in Europe. Laura has served as a Principal Clinical Affairs Advisor of several medical device companies acquired by Covidien, Boston Scientific, Medtronic and Johnson & Johnson Interventional Systems.
WEBVTT
00:00:04.900 --> 00:00:07.839
Welcome to the LATAM Medtech Leaders Podcast.
00:00:08.169 --> 00:00:13.210
This is a weekly conversation with MedTech leaders who have succeeded in Latin America.
00:00:14.380 --> 00:00:17.280
Today our guest is Laura Minarsch.
00:00:17.280 --> 00:00:22.280
Laura is a senior clinical affairs strategist and President of MMC Medical International Services.
00:00:25.210 --> 00:00:33.850
She consults for several novel innovative medical device companies and has facilitated numerous acquisitions over her 25-year career.
00:00:33.850 --> 00:00:45.039
Her track record is based on successful and strategically planned“First in Human” submissions and clinical studies in Europe, Canada, South America, New Zealand, and Australia.
00:00:45.040 --> 00:00:57.579
Laura began her career as a Registered Cardiovascular Invasive Specialist, and Interventional Cardiovascular Specialist implementing several first interventional device programs in Europe.
00:00:57.581 --> 00:01:08.500
Laura has served as a Principal Clinical Affairs Advisor of several medical device companies acquired by Covidien, Boston Scientific, Medtronic, and Johnson& Johnson.
00:01:08.530 --> 00:01:10.659
Laura, welcome to the show.
00:01:11.349 --> 00:01:12.010
Good morning!
00:01:12.950 --> 00:01:13.790
How do you doing?
00:01:14.049 --> 00:01:14.469
Good.
00:01:14.989 --> 00:01:16.310
Thank you for joining the call.
00:01:17.030 --> 00:01:20.879
Also, thank you for accepting my invitation to speak today.
00:01:20.881 --> 00:01:23.819
I truly look forward to this conversation today.
00:01:24.340 --> 00:01:25.659
Okay, well, let's see.
00:01:25.661 --> 00:01:26.590
What can I help with?
00:01:27.099 --> 00:01:29.319
Well, Laura, two things here.
00:01:29.689 --> 00:01:31.659
I have two items for the agenda.
00:01:31.661 --> 00:01:42.109
First is the conversation about the EU MDR, you seem to have a very fascinating experiencing in clinical research and regulatory affairs.
00:01:42.111 --> 00:01:46.849
I sent you some of the questions that I have on the topic.
00:01:49.180 --> 00:01:49.540
I got it.
00:01:50.100 --> 00:01:57.219
In light of the rigor of the European MDR, are US medtech companies still considering Europe?
00:01:58.269 --> 00:02:01.980
To answer the first question, yes, absolutely.
00:02:02.569 --> 00:02:21.860
But what's happening right now is that a lot of small medtech companies are approaching sort of a parallel path where by depending on how far along they are, they might be looking at the FDA.
00:02:21.860 --> 00:02:31.449
the agency is now trying to entice a lot of small technology companies to spend more time in the United States and less time outside the United States.
00:02:32.120 --> 00:02:36.909
So the early ugliness platform is very enticing.
00:02:37.479 --> 00:02:53.919
So some companies are approaching a parallel path in that thereafter they do their first-in-human essay and feel comfortable with where they're at with that, which is definitely likely not to be in the US and likely to be in a non-tier one country.
00:02:53.920 --> 00:03:09.580
Then once they've achieved that hurdle, then they moved into a parallel path that could involve in early feasibility plan and a European plan at the same time.
00:03:09.580 --> 00:03:11.639
It's sort of a parallel path.
00:03:11.640 --> 00:03:38.979
Before the new regulations are implemented in June of 2020, some companies are actually expediting there application with notified bodies to get involved with the CE Mark strategy on the earlier side.
00:03:39.129 --> 00:03:49.599
There's a couple of notified bodies that are very excited to provide the early modules, even if clinicals haven't been executed yet.
00:03:49.600 --> 00:03:52.569
So that's a lengthy answer to the first question.
00:03:53.610 --> 00:03:55.860
Very accurate and very comprehensive.
00:03:55.860 --> 00:03:56.280
Very good.
00:03:56.281 --> 00:03:56.750
Thank you for that.
00:03:56.770 --> 00:03:58.289
Alright, second question.
00:03:59.479 --> 00:03:59.659
Yeah.
00:04:00.150 --> 00:04:09.669
If yours is a medical device design, development, and commercialization company, what’s been your company experience with EU MDR?
00:04:10.390 --> 00:04:15.729
My company provides a strategy for a very early phase.
00:04:15.789 --> 00:04:18.639
I'm primarily focused on First-in-Human.
00:04:19.129 --> 00:04:26.509
So the work that I do is provide a clinical strategy for the very first time something's used.
00:04:27.720 --> 00:04:32.529
So my work with the European MDR.
00:04:32.531 --> 00:04:56.490
I'm only realizing this phase once we've gotten into, there's a couple of companies that I consult for where we're conducting registries in Europe, we're conducting clinical and where I'm writing a protocol that's designed to support a CE Mark submission.
00:04:56.490 --> 00:05:01.689
So at that point then the EU MDR becomes really much more important for me.
00:05:01.690 --> 00:05:10.889
But that's a smaller percentage of the companies that I consult where I would say probably 20%, the other 80% is a very early chase.
00:05:10.891 --> 00:05:20.389
I think there's, a lot of value to conduct classes on the European MDR.
00:05:20.540 --> 00:05:38.029
I think that a lot of regulatory consultants, quality consultants and clinical consultants, like myself, would be very interested to take classes to understand better so that they can consult better for their clients.
00:05:38.031 --> 00:05:43.610
How has the European MDR affected your company's commercialization strategy?
00:05:43.610 --> 00:05:48.649
I'm not really involved in the commercialization strategy, so I've probably can't speak to that.
00:05:48.800 --> 00:05:49.040
Okay.
00:05:49.040 --> 00:05:51.620
What about the clinical strategy?
00:05:52.319 --> 00:05:53.730
The clinical strategy?
00:05:53.850 --> 00:06:05.009
Again, I think what we're doing now is we're trying to advise companies to maybe get in with an application to a notified body on the earlier side.
00:06:04.591 --> 00:06:16.790
I can't really speak to commercialization other than in that 20% of clients that I work with that have CE Mark already.
00:06:17.790 --> 00:06:43.540
I've been heavily involved with supporting the registries, supporting the postmark clinical follow up and supporting their efforts with regards to vigilance and connecting with a European authorized representatives and how the cost for a European authorized representative is increasing because the responsibilities for reporting are much greater.
00:06:44.509 --> 00:06:46.040
Out of curiosity, how much is it now?
00:06:46.300 --> 00:06:47.529
Well, how much it was before?
00:06:47.759 --> 00:07:05.860
Well, you could secure an agreement with the company to be your European authorized representative for a couple of thousand dollars a year, and now because the responsibilities for reporting are so much freighter and the EA have much more to be responsible for.
00:07:06.290 --> 00:07:09.339
They're charging more relative to that.
00:07:09.370 --> 00:07:12.120
So a couple of thousand dollars a month.
00:07:12.120 --> 00:07:13.230
It's a whole new business.
00:07:13.230 --> 00:07:17.129
For example, there are CROs in Europe that provide the service.
00:07:17.439 --> 00:07:33.100
There is a clinical consulting, a company based in Germany that provides the service, they pop up everywhere companies that provide a European authorized representative service, but it comes with lots of responsibilities.
00:07:33.490 --> 00:07:37.519
So they're charging more and that's a whole new business platform.
00:07:37.521 --> 00:07:45.449
Let's see: Are MedTech companies considering other alternative markets to the European Union?
00:07:45.451 --> 00:07:48.689
They can start generating revenue faster.
00:07:48.839 --> 00:07:52.009
So is Latin America one of those markets?
00:07:52.011 --> 00:08:01.399
No, I don't see MedTech companies considering alternative markets to the European Union for revenue purposes.
00:08:01.401 --> 00:08:15.740
The Latin American market with the companies that I work with at the very early phase, we do a lot of work in Latin America, pre-commercialization.
00:08:17.480 --> 00:08:20.000
So not so much from a commercial perspective.
00:08:20.000 --> 00:08:28.759
I think if I understood a little bit more about the post-market phase and what Latin America could offer, I could maybe advise clients better.
00:08:28.761 --> 00:08:36.210
But I don't see any of the companies that I work with looking at Latin America as an alternative to Europe.
00:08:37.210 --> 00:08:37.539
Okay.
00:08:39.370 --> 00:08:44.710
What are your general thoughts on early-stage clinical trials or selling medical devices in Latin America?
00:08:44.711 --> 00:09:01.769
I think we liked very much going to Colombia, we liked very much going to Brazil, which I think is equivalent to Germany far as how it is viewed upon for submissions both in the US and in Europe.
00:09:01.770 --> 00:09:12.870
I think data collected in Brazil is a very high quality, so lots of my companies like to conduct trials in Brazil.
00:09:12.870 --> 00:09:19.830
Obviously I do a lot of work in Paraguay because it's an approval sort of a private hospital setting.
00:09:19.831 --> 00:09:28.320
So companies want to get experience at a very early phase can go there and stay sort of under the radar before they go to Europe.
00:09:28.321 --> 00:09:39.330
So we do work in the Dominican Republic, we do work in Panama on a limited basis, we do work in Paraguay, Colombia, Brazil, Chile.
00:09:39.820 --> 00:09:41.059
That's about it.
00:09:41.750 --> 00:09:42.110
Okay.
00:09:43.370 --> 00:09:46.100
Have you heard about the Pacific Alliance in Latin America?
00:09:46.480 --> 00:09:47.200
I've heard about it.
00:09:47.201 --> 00:09:48.460
I don't know that much about it.
00:09:48.830 --> 00:09:53.299
I would be very interested to learn a little bit more about it.
00:09:53.730 --> 00:10:06.529
It was a company that I work with, a CRO in Brazil called CRC or HCor, Hcor actually acquired CRC.
00:10:07.440 --> 00:10:09.360
So they do a lot of this submission.
00:10:09.389 --> 00:10:11.409
They h elped me with my submission p latform.
00:10:11.990 --> 00:10:15.950
There's a group out of Yale that I worked with.
00:10:16.200 --> 00:10:19.830
Oh, that's Cardiovid.
00:10:20.940 --> 00:10:22.259
I worked with them before.
00:10:23.860 --> 00:10:24.909
Yes, exactly.
00:10:25.990 --> 00:10:31.820
Then, I have a client that wants to approach something a little bizarre.
00:10:33.551 --> 00:10:45.370
I've had clients that wanted to go to Panama and when you go to Panama, there aren't real ethics committees and then if there's not an ethics committee in a company want to go to a certain facility.
00:10:45.759 --> 00:10:52.610
I've actually written a charter and hired an ethics committee and put an ethics committee together to support the submissions.
00:10:53.370 --> 00:10:55.559
Yeah, okay.
00:10:56.350 --> 00:11:02.059
So let's go back to the drawing board and so they bought the shoes first and then we have to get the hat and the dress and everything else.
00:11:05.159 --> 00:11:05.669
Yeah.
00:11:05.159 --> 00:11:10.350
A couple of months ago with a site in Colombia, with a clinic in Columbia.
00:11:10.350 --> 00:11:17.710
They didn't have an ethics committee, but the sponsor, which actually Hancock Jaffe a company out of Orange County, very close to where you are.
00:11:17.889 --> 00:11:19.929
Well, I went over there because Mark Glickman.
00:11:20.639 --> 00:11:21.750
Yeah, he's a good friend.
00:11:25.970 --> 00:11:32.639
He just came back from Colombia, this is like his third or fourth trip and that we're conducting a trial at a site with Doctor Ulloa.
00:11:32.250 --> 00:11:51.480
Ulloa is a Vascular Surgeon who trained in the US and they called me because they wanted to conduct the trial at Doctor Ulloa's clinic, but the clinic didn't have an ethics committee, so I did everything to make that committee approval.
00:11:50.840 --> 00:11:56.769
Of course, we have to sit there at this committee and then we went to INVIMA, which is the regulatory agency.
00:11:56.370 --> 00:11:59.669
So it's already running.
00:11:59.970 --> 00:12:00.269
Yeah.
00:12:00.270 --> 00:12:08.970
So Mark and I were on a DSMB call yesterday for about an hour and a half with another company that's in the vascular access space and he sits on that.
00:12:09.440 --> 00:12:10.789
He's on the DSMB board.
00:12:11.000 --> 00:12:18.090
So he was telling us about just coming back, but came over to Hancock Jaffe because I worked with Warren Hancock many years ago.
00:12:18.090 --> 00:12:28.279
I've been in the industry for a long time and Warren was a wonderful guy and I knew MR.
00:12:28.730 --> 00:12:40.679
Jaffe as well, so I went over there and I was consulting with them before they, you know, I forget the guy who was the CEO, but they were asking me questions about getting approvals down there.
00:12:43.471 --> 00:12:51.019
So I really didn't get too involved with that because again, for me to do things down there, I have to partner with somebody.
00:12:52.129 --> 00:12:57.440
I told you who I partner with for Brazil and Panama, we sort of did our own thing.
00:12:58.139 --> 00:13:00.370
Well, you already have a new partner in Colombia now.
00:13:02.429 --> 00:13:17.019
Yeah, I actually did a submission in Colombia on my own for a company that had a device for atrial fibrillation and we were submitting, I'm looking it up right now.
00:13:17.389 --> 00:13:17.840
Mitralign?
00:13:18.259 --> 00:13:18.590
MitraSpan?
00:13:19.970 --> 00:13:22.279
No, it was an AF device.
00:13:22.280 --> 00:13:31.149
It was for a PAMA, which was acquired by Boston Scientific, but we were working with William Uribe, with university CES.
00:13:31.149 --> 00:14:00.850
Jorge Gomez was the president of the ethic committee down there, and I got approval actually, and I got to the point of going to INVIMA and then Boston scientific acquired PAMA and then we never went any farther, but I did the whole submission on my own.
00:14:02.360 --> 00:14:03.299
Impressive! And you speak Spanish, I imagine?
00:14:04.009 --> 00:14:06.889
No, I speak Italian, which I got everything translated.
00:14:06.140 --> 00:14:17.769
But we were there because we were working with Vivek Reddy, out of Mount Sinai and Vivek wanted to work with William Uribe.
00:14:18.320 --> 00:14:19.580
He wanted to go to Colombia.
00:14:19.750 --> 00:14:25.289
That of going to a Paraguay or some other place that he was less than failure with.
00:14:26.250 --> 00:14:26.909
Interesting.
00:14:27.630 --> 00:14:34.740
I don't know if you know something about our story, but we started because of my brother’s work through the University of Miami.
00:14:34.740 --> 00:14:37.169
He's an interventional cardiologist, Pedro.
00:14:38.009 --> 00:14:40.889
He started traveling to Paraguay with Dr.
00:14:41.149 --> 00:14:44.059
Adrian Ebner and that's probably who you're referring to.
00:14:50.929 --> 00:14:51.950
So we know him well.
00:14:52.429 --> 00:14:55.490
Pedro is been there a few times, he worked with him.
00:14:55.730 --> 00:15:08.360
He trained at the University of Miami if I remember correctly, and that's the affiliation that he had with the university and that's how Pedro, my brother, he was a professor in the university and he ended up doing trials with him and then he also ended up in Colombia.
00:15:08.440 --> 00:15:09.639
He must know me then.
00:15:10.500 --> 00:15:10.860
Yes.
00:15:13.230 --> 00:15:14.700
Your name sounds very familiar.
00:15:14.701 --> 00:15:16.500
I mean, I'm sure my brother knows you.
00:15:17.580 --> 00:15:20.759
He has to because I'm doing things in Paraguay.
00:15:20.760 --> 00:15:22.529
I'm leaving Sunday, I'm down there.
00:15:22.879 --> 00:15:27.409
I've been going down there, taking companies down there for 12 years.
00:15:27.940 --> 00:15:28.750
Wow, fantastic.
00:15:33.659 --> 00:15:35.519
Is it a CRO in Paraguay?
00:15:35.929 --> 00:15:37.759
It's anybody who's helping you with all these or not?
00:15:38.710 --> 00:15:39.730
I'm the CRO.
00:15:40.159 --> 00:15:40.669
Interesting.
00:15:40.671 --> 00:15:42.070
What about the importation of the device?
00:15:42.070 --> 00:15:44.669
Don't you need like a local third party or something?
00:15:45.620 --> 00:15:51.259
No, we do it with Adrian and he walks us through.
00:15:52.340 --> 00:15:52.909
That's what I heard.
00:15:53.240 --> 00:15:54.259
Costumes and everything.
00:15:54.260 --> 00:15:55.039
Yeah, that's what I heard.
00:15:58.730 --> 00:16:11.620
In fact, we just did the entire clinical trials for millipede medical in Paraguay and they were just acquired in January by Boston Scientific.
00:16:11.889 --> 00:16:12.509
Impressive.
00:16:12.510 --> 00:16:13.509
I mean, congratulations!
00:16:13.740 --> 00:16:25.440
So that's why I'm more involved and much more expertise in the early phase of efforts for clients more so than later on.
00:16:26.370 --> 00:16:26.909
Sure.
00:16:27.389 --> 00:16:27.990
Okay.
00:16:27.389 --> 00:16:32.139
I'd like to clarify, something is been kind of intriguing me for a while.
00:16:33.090 --> 00:16:48.299
Paraguay, am I correct in saying that Paraguay is a very good place for early-stage trials, cardiovascular devices, but anything other than that is difficult because you don't have an equivalent Adrian Ebner, no other therapeutic areas.
00:16:48.460 --> 00:16:49.419
Is that correct or not?
00:16:50.480 --> 00:16:53.179
So there's a couple of different answers to that.
00:16:53.210 --> 00:17:01.470
With a PAMA that I was talking about a little bit earlier, that's an electrophysiology device and they don't really do electrophysiology down there.
00:17:01.471 --> 00:17:07.930
They don't have the economy to support all of the equipment that you need.
00:17:08.740 --> 00:17:17.980
We did our first four patients for a PAMA down in Paraguay, just approve our catheter feasibility and we brought all of the equipment down there.
00:17:18.319 --> 00:17:26.569
We actually shipped it all, and there's been a couple of companies that actually have shipped down robotic equipment.
00:17:26.900 --> 00:17:30.720
They were doing robotic and laser for example.
00:17:30.721 --> 00:17:48.569
So you can do whatever you want to do in that lab because he runs that lab, but to realize that it's just basically a cath lab, but because Adrian is a Cardiac Surgeon and an Interventional Cardiologist.
00:17:50.039 --> 00:17:52.920
That's why it's primarily cardiology.
00:17:53.099 --> 00:18:04.480
It's his expertise or he partners with someone who's in the endovascular or the vascular peripheral space.
00:18:04.509 --> 00:18:13.529
If you partner with somebody like that and they're willing to come to his facility, then he can do whatever a client needs.
00:18:13.530 --> 00:18:19.829
So the only reason why it's been primarily cardiology is because this is a project that Adrian put together.
00:18:20.819 --> 00:18:31.480
You go there and companies love it because they can make his facility their own, they can bring their own operators.
00:18:31.920 --> 00:18:47.559
So if you've got one investigator and he's doing all the animal preclinical work here in the United States, you can't take someone like that to Brazil to Dante Pazzanese, have him and do cases, you can't do that.
00:18:47.859 --> 00:18:48.220
Yeah.
00:18:48.250 --> 00:18:50.900
We've done the same thing in Colombia for Mitralign and MitraSpan.
00:18:50.900 --> 00:18:50.900
Yeah.
00:18:54.391 --> 00:19:08.180
So when you go to the Czech Republic or Poland or any of the European locations, you also struggle with being able to have your physician from the US scrubbing and participating.
00:19:08.599 --> 00:19:08.599
Yeah.
00:19:11.619 --> 00:19:12.039
Awesome.
00:19:12.040 --> 00:19:12.400
Laura.
00:19:12.401 --> 00:19:18.589
I mean, so if there's anything I can do to help in Colombia with one of your clients, I mean, we can partner up with that.
00:19:18.381 --> 00:19:20.960
I mean there'll be a very interesting collaboration.
00:19:21.630 --> 00:19:22.079
Yeah, absolutely.
00:19:22.770 --> 00:19:43.089
I mean if you have anything that you can send me that sort of a detailed, like for what I did for a PAMA where I did it on my own, I would have used you, cause it wasn't that, it was for a lack of fun that we were making those efforts to Colombia was just because I didn't have anybody else.
00:19:43.900 --> 00:19:50.289
Basically he and I, but in the future, I would rather work with someone like yourself.
00:19:51.710 --> 00:19:52.940
Yeah, I have a whole team.
00:19:53.299 --> 00:19:55.670
We've done this for 10 years already.
00:19:57.250 --> 00:19:57.460
Thanks, Julio.
00:19:57.250 --> 00:19:58.119
Thank you so much.
00:19:58.529 --> 00:20:03.400
I have been really a pleasure getting to know you over the phone and I look forward to meeting you in person someday.
00:20:03.599 --> 00:20:04.019
Hopefully.
00:20:04.609 --> 00:20:11.130
Yeah, I do too as well and I'm sure Pedro knows who I am or seeing my name float around.
00:20:11.131 --> 00:20:14.640
So we're actually getting on a plane on Sunday to go to Paraguay.
00:20:15.539 --> 00:20:15.980
Awesome.
00:20:16.970 --> 00:20:17.450
Okay.
00:20:18.069 --> 00:20:22.250
Much success with your trip to Paraguay and I look forward to getting back in touch.
00:20:21.980 --> 00:20:24.769
Alright, bye, have a great weekend.
00:20:25.450 --> 00:20:25.839
You too.
00:00:04.900 --> 00:00:07.839
00:00:08.169 --> 00:00:13.210
00:00:14.380 --> 00:00:17.280
00:00:17.280 --> 00:00:22.280
00:00:25.210 --> 00:00:33.850
00:00:33.850 --> 00:00:45.039
00:00:45.040 --> 00:00:57.579
00:00:57.581 --> 00:01:08.500
00:01:08.530 --> 00:01:10.659
00:01:11.349 --> 00:01:12.010
00:01:12.950 --> 00:01:13.790
00:01:14.049 --> 00:01:14.469
00:01:14.989 --> 00:01:16.310
00:01:17.030 --> 00:01:20.879
00:01:20.881 --> 00:01:23.819
00:01:24.340 --> 00:01:25.659
00:01:25.661 --> 00:01:26.590
00:01:27.099 --> 00:01:29.319
00:01:29.689 --> 00:01:31.659
00:01:31.661 --> 00:01:42.109
00:01:42.111 --> 00:01:46.849
00:01:49.180 --> 00:01:49.540
00:01:50.100 --> 00:01:57.219
00:01:58.269 --> 00:02:01.980
00:02:02.569 --> 00:02:21.860
00:02:21.860 --> 00:02:31.449
00:02:32.120 --> 00:02:36.909
00:02:37.479 --> 00:02:53.919
00:02:53.920 --> 00:03:09.580
00:03:09.580 --> 00:03:11.639
00:03:11.640 --> 00:03:38.979
00:03:39.129 --> 00:03:49.599
00:03:49.600 --> 00:03:52.569
00:03:53.610 --> 00:03:55.860
00:03:55.860 --> 00:03:56.280
00:03:56.281 --> 00:03:56.750
00:03:56.770 --> 00:03:58.289
00:03:59.479 --> 00:03:59.659
00:04:00.150 --> 00:04:09.669
00:04:10.390 --> 00:04:15.729
00:04:15.789 --> 00:04:18.639
00:04:19.129 --> 00:04:26.509
00:04:27.720 --> 00:04:32.529
00:04:32.531 --> 00:04:56.490
00:04:56.490 --> 00:05:01.689
00:05:01.690 --> 00:05:10.889
00:05:10.891 --> 00:05:20.389
00:05:20.540 --> 00:05:38.029
00:05:38.031 --> 00:05:43.610
00:05:43.610 --> 00:05:48.649
00:05:48.800 --> 00:05:49.040
00:05:49.040 --> 00:05:51.620
00:05:52.319 --> 00:05:53.730
00:05:53.850 --> 00:06:05.009
00:06:04.591 --> 00:06:16.790
00:06:17.790 --> 00:06:43.540
00:06:44.509 --> 00:06:46.040
00:06:46.300 --> 00:06:47.529
00:06:47.759 --> 00:07:05.860
00:07:06.290 --> 00:07:09.339
00:07:09.370 --> 00:07:12.120
00:07:12.120 --> 00:07:13.230
00:07:13.230 --> 00:07:17.129
00:07:17.439 --> 00:07:33.100
00:07:33.490 --> 00:07:37.519
00:07:37.521 --> 00:07:45.449
00:07:45.451 --> 00:07:48.689
00:07:48.839 --> 00:07:52.009
00:07:52.011 --> 00:08:01.399
00:08:01.401 --> 00:08:15.740
00:08:17.480 --> 00:08:20.000
00:08:20.000 --> 00:08:28.759
00:08:28.761 --> 00:08:36.210
00:08:37.210 --> 00:08:37.539
00:08:39.370 --> 00:08:44.710
00:08:44.711 --> 00:09:01.769
00:09:01.770 --> 00:09:12.870
00:09:12.870 --> 00:09:19.830
00:09:19.831 --> 00:09:28.320
00:09:28.321 --> 00:09:39.330
00:09:39.820 --> 00:09:41.059
00:09:41.750 --> 00:09:42.110
00:09:43.370 --> 00:09:46.100
00:09:46.480 --> 00:09:47.200
00:09:47.201 --> 00:09:48.460
00:09:48.830 --> 00:09:53.299
00:09:53.730 --> 00:10:06.529
00:10:07.440 --> 00:10:09.360
00:10:09.389 --> 00:10:11.409
00:10:11.990 --> 00:10:15.950
00:10:16.200 --> 00:10:19.830
00:10:20.940 --> 00:10:22.259
00:10:23.860 --> 00:10:24.909
00:10:25.990 --> 00:10:31.820
00:10:33.551 --> 00:10:45.370
00:10:45.759 --> 00:10:52.610
00:10:53.370 --> 00:10:55.559
00:10:56.350 --> 00:11:02.059
00:11:05.159 --> 00:11:05.669
00:11:05.159 --> 00:11:10.350
00:11:10.350 --> 00:11:17.710
00:11:17.889 --> 00:11:19.929
00:11:20.639 --> 00:11:21.750
00:11:25.970 --> 00:11:32.639
00:11:32.250 --> 00:11:51.480
00:11:50.840 --> 00:11:56.769
00:11:56.370 --> 00:11:59.669
00:11:59.970 --> 00:12:00.269
00:12:00.270 --> 00:12:08.970
00:12:09.440 --> 00:12:10.789
00:12:11.000 --> 00:12:18.090
00:12:18.090 --> 00:12:28.279
00:12:28.730 --> 00:12:40.679
00:12:43.471 --> 00:12:51.019
00:12:52.129 --> 00:12:57.440
00:12:58.139 --> 00:13:00.370
00:13:02.429 --> 00:13:17.019
00:13:17.389 --> 00:13:17.840
00:13:18.259 --> 00:13:18.590
00:13:19.970 --> 00:13:22.279
00:13:22.280 --> 00:13:31.149
00:13:31.149 --> 00:14:00.850
00:14:02.360 --> 00:14:03.299
00:14:04.009 --> 00:14:06.889
00:14:06.140 --> 00:14:17.769
00:14:18.320 --> 00:14:19.580
00:14:19.750 --> 00:14:25.289
00:14:26.250 --> 00:14:26.909
00:14:27.630 --> 00:14:34.740
00:14:34.740 --> 00:14:37.169
00:14:38.009 --> 00:14:40.889
00:14:41.149 --> 00:14:44.059
00:14:50.929 --> 00:14:51.950
00:14:52.429 --> 00:14:55.490
00:14:55.730 --> 00:15:08.360
00:15:08.440 --> 00:15:09.639
00:15:10.500 --> 00:15:10.860
00:15:13.230 --> 00:15:14.700
00:15:14.701 --> 00:15:16.500
00:15:17.580 --> 00:15:20.759
00:15:20.760 --> 00:15:22.529
00:15:22.879 --> 00:15:27.409
00:15:27.940 --> 00:15:28.750
00:15:33.659 --> 00:15:35.519
00:15:35.929 --> 00:15:37.759
00:15:38.710 --> 00:15:39.730
00:15:40.159 --> 00:15:40.669
00:15:40.671 --> 00:15:42.070
00:15:42.070 --> 00:15:44.669
00:15:45.620 --> 00:15:51.259
00:15:52.340 --> 00:15:52.909
00:15:53.240 --> 00:15:54.259
00:15:54.260 --> 00:15:55.039
00:15:58.730 --> 00:16:11.620
00:16:11.889 --> 00:16:12.509
00:16:12.510 --> 00:16:13.509
00:16:13.740 --> 00:16:25.440
00:16:26.370 --> 00:16:26.909
00:16:27.389 --> 00:16:27.990
00:16:27.389 --> 00:16:32.139
00:16:33.090 --> 00:16:48.299
00:16:48.460 --> 00:16:49.419
00:16:50.480 --> 00:16:53.179
00:16:53.210 --> 00:17:01.470
00:17:01.471 --> 00:17:07.930
00:17:08.740 --> 00:17:17.980
00:17:18.319 --> 00:17:26.569
00:17:26.900 --> 00:17:30.720
00:17:30.721 --> 00:17:48.569
00:17:50.039 --> 00:17:52.920
00:17:53.099 --> 00:18:04.480
00:18:04.509 --> 00:18:13.529
00:18:13.530 --> 00:18:19.829
00:18:20.819 --> 00:18:31.480
00:18:31.920 --> 00:18:47.559
00:18:47.859 --> 00:18:48.220
00:18:48.250 --> 00:18:50.900
00:18:50.900 --> 00:18:50.900
00:18:54.391 --> 00:19:08.180
00:19:08.599 --> 00:19:08.599
00:19:11.619 --> 00:19:12.039
00:19:12.040 --> 00:19:12.400
00:19:12.401 --> 00:19:18.589
00:19:18.381 --> 00:19:20.960
00:19:21.630 --> 00:19:22.079
00:19:22.770 --> 00:19:43.089
00:19:43.900 --> 00:19:50.289
00:19:51.710 --> 00:19:52.940
00:19:53.299 --> 00:19:55.670
00:19:57.250 --> 00:19:57.460
00:19:57.250 --> 00:19:58.119
00:19:58.529 --> 00:20:03.400
00:20:03.599 --> 00:20:04.019
00:20:04.609 --> 00:20:11.130
00:20:11.131 --> 00:20:14.640
00:20:15.539 --> 00:20:15.980
00:20:16.970 --> 00:20:17.450
00:20:18.069 --> 00:20:22.250
00:20:21.980 --> 00:20:24.769
00:20:25.450 --> 00:20:25.839